Sterne Agee Reiterates Buy on IBM (IBM)

By admin | 6 years ago

IBM (NYSE: IBM)‘s stock had its “buy” rating reiterated by equities research analysts at Sterne Agee in a research note issued to investors on Thursday.

A number of other analysts have also recently weighed in on IBM. Analysts at Barclays Capital (NYSE: BCS) reiterated an “equalweight” rating on shares of IBM in a research note to investors on Monday. Separately, analysts at RBC Capital (NYSE: RY) raised their price target on shares of IBM from $200.00 to $215.00 in a research note to investors on Wednesday, April 18th. They now have a “sector perform” rating on the stock.

IBM traded up 0.60% on Thursday, hitting $201.81. IBM has a 52-week low of $157.13 and a 52-week high of $210.69. The company has a market cap of $232.8 billion and a price-to-earnings ratio of 14.96.

IBM last posted its quarterly earnings results on Tuesday, April 17th. The company reported $2.78 earnings per share for the quarter, beating the analysts’ consensus estimate of $2.63 by $0.15. IBM’s revenue was up .4% compared to the same quarter last year. Analysts expect that IBM will post $3.63 EPS next quarter.

International Business Machines Corporation (IBM) is an information technology (IT) company. IBM’s segments include Global Technology Services (GTS), Global Business Services (GBS), Software, Systems and Technology and Global Financing.

About the author